Biological
Deramiocel clinical trials
Also written CAP-1002 and Allogeneic Cardiosphere-Derived Cells.
- studies test it
- 10
- open now
- 0
- in phase 3
- 1
- first study started
- 2012
How studies write it
Studies that test it under each name
Development codes
Other names
Studies by the year they started
10 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 7
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 2
Capricor Inc. (8) · Cedars-Sinai Medical Center (2)
Studies
Open first, then newest update. How each study uses deramiocel is read from its arms, and is right about nine times in ten.
Testing it · 10
- Open-label Extension of the HOPE-2 TrialActive, not recruitingPhase 2Capricor Inc.NCT04428476Written as Deramiocel (CAP-1002)
- A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular DystrophyActive, not recruitingPhase 3Capricor Inc.NCT05126758Written as Deramiocel (CAP-1002)
- A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular DystrophyCompletedPhase 2Capricor Inc.NCT03406780Written as CAP-1002
- Intravenous Infusion of CAP-1002 in Patients With COVID-19CompletedPhase 2Capricor Inc.NCT04623671Written as CAP-1002
- HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)CompletedPhase 2Capricor Inc.NCT02485938Written as Allogeneic Cardiosphere-Derived Cells (CAP-1002)
- Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFpEF Patients Treated With Allogeneic CDCsCompletedPhase 2Cedars-Sinai Medical CenterNCT02941705Written as Allogeneic Derived Cells
- Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)CompletedPhase 2Capricor Inc.NCT06304064Written as Allogeneic Cardiosphere-Derived Cells (CAP-1002)
- Allogeneic Heart Stem Cells to Achieve Myocardial RegenerationTerminatedPhase 1/2Capricor Inc.NCT01458405Written as CAP-1002 Allogeneic Cardiosphere-Derived Cells
- ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApyCompletedPhase 1Cedars-Sinai Medical CenterNCT03145298Written as Allogeneic Human Cardiosphere-Derived Stem Cells
- Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)Status unknownPhase 1Capricor Inc.NCT02293603Written as Allogeneic Cardiosphere-Derived Cells (CDCs)
Codes
What other systems call deramiocel · ClinicalTrials.gg INT018699
- UNII (FDA) ZM7OCV7H6HDERAMIOCELOne source FDA
- NCI Thesaurus C220985DeramiocelOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | ZM7OCV7H6H | DERAMIOCEL | One source FDA |
| NCI Thesaurus | C220985 | Deramiocel | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.